These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18560590)

  • 1. Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination.
    Bouchez V; Caro V; Levillain E; Guigon G; Guiso N
    PLoS One; 2008 Jun; 3(6):e2437. PubMed ID: 18560590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomics of whole-cell pertussis vaccine strains from India.
    Alai S; Ghattargi VC; Gautam M; Patel K; Pawar SP; Dhotre DP; Shaligram U; Gairola S
    BMC Genomics; 2020 May; 21(1):345. PubMed ID: 32381023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome characteristics of
    Ben Fraj I; Bouchez V; Smaoui H; Kechrid A; Brisse S
    J Med Microbiol; 2019 Sep; 68(9):1320-1323. PubMed ID: 31329091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains.
    Heikkinen E; Kallonen T; Saarinen L; Sara R; King AJ; Mooi FR; Soini JT; Mertsola J; He Q
    PLoS One; 2007 Sep; 2(9):e904. PubMed ID: 17878939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variation of Bordetella pertussis in Austria.
    Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
    PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.
    Kallonen T; Gröndahl-Yli-Hannuksela K; Elomaa A; Lutyńska A; Fry NK; Mertsola J; He Q
    Infect Genet Evol; 2011 Dec; 11(8):2034-42. PubMed ID: 21964035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic epidemiology of Iranian
    Safarchi A; Octavia S; Nikbin VS; Lotfi MN; Zahraei SM; Tay CY; Lamichhane B; Shahcheraghi F; Lan R
    Emerg Microbes Infect; 2019; 8(1):1416-1427. PubMed ID: 31543006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
    Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
    Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
    Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
    J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis and comparison of Bordetella pertussis isolates circulating in low and high vaccine coverage areas.
    Njamkepo E; Cantinelli T; Guigon G; Guiso N
    Microbes Infect; 2008; 10(14-15):1582-6. PubMed ID: 18977453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.
    Weigand MR; Pawloski LC; Peng Y; Ju H; Burroughs M; Cassiday PK; Davis JK; DuVall M; Johnson T; Juieng P; Knipe K; Loparev VN; Mathis MH; Rowe LA; Sheth M; Williams MM; Tondella ML
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin.
    Hegerle N; Paris AS; Brun D; Dore G; Njamkepo E; Guillot S; Guiso N
    Clin Microbiol Infect; 2012 Sep; 18(9):E340-6. PubMed ID: 22717007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003.
    Byrne S; Slack AT
    BMC Infect Dis; 2006 Mar; 6():53. PubMed ID: 16542440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.
    Packard ER; Parton R; Coote JG; Fry NK
    J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-locus variable-number tandem repeat analysis of Bordetella pertussis isolates circulating in Poland in the period 1959-2013.
    Mosiej E; Krysztopa-Grzybowska K; Polak M; Prygiel M; Lutyńska A
    J Med Microbiol; 2017 Jun; 66(6):753-761. PubMed ID: 28598302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences of circulating Bordetella pertussis population in Argentina from the strain used in vaccine production.
    Fingermann M; Fernández J; Sisti F; Rodríguez ME; Gatti B; Bottero D; Graieb A; Gaillard ME; Ayala SG; Mooi FR; Lopardo H; Hozbor D
    Vaccine; 2006 Apr; 24(17):3513-21. PubMed ID: 16545509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
    Bailon H; León-Janampa N; Padilla C; Hozbor D
    BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
    Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
    J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.